A recombinant dromedary antibody fragment (VHH or nanobody) directed against human Duffy antigen receptor for chemokines

Cellular and Molecular Life Sciences

Volumn 67, Issue 19, 2010, Pages 3371-3387

  Smolarek, Dorota ^a,b,c,d   Hattab, Claude ^a,c,d   Hassanzadeh Ghassabeh, Gholamreza ^e,f   Cochet, Sylvie ^a,c,d   Gutiérrez, Carlos ^g   De Brevern, Alexandre G ^a,c,d   Udomsangpetch, Rachanee ^h   Picot, Julien ^a,c,d   Grodecka, Magdalena ^b   Wasniowska, Kazimiera ^b   Muyldermans, Serge ^e,f   Colin, Yves ^a,c,d   Le Van Kim, Caroline ^a,c,d   Czerwinski, Marcin ^b   Bertrand, Olivier ^a,c,d  

^a hôpital Robert Debré et Institut national de la transfusion sanguine   (France)

^b INSTITUTE OF IMMUNOLOGY AND EXPERIMENTAL THERAPY   (Poland)

^c INSTITUT NATIONAL DE LA TRANSFUSION SANGUINE   (France)

^d UNIVERSITÉ PARIS DESCARTES   (France)

^e VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

^f DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

^g UNIVERSITY OF LAS PALMAS DE GRAN CANARIA   (Spain)

^h MAHIDOL UNIVERSITY   (Thailand)

Author keywords

Atypical chemokine receptor; Cancer; Duffy antigen receptor for chemokines; HIV; Immunoaffinity; Inflammation; Plasmodium vivax; VHH

Indexed keywords

DUFFY ANTIGEN RECEPTOR FOR CHEMOKINE; EPITOPE; INTERLEUKIN 8; LYMPHOCYTE ANTIGEN RECEPTOR; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ANIMAL EXPERIMENT; ANTIBODY AFFINITY; ANTIGEN BINDING; ANTIGEN PURIFICATION; ANTIGEN SPECIFICITY; ARTICLE; BINDING KINETICS; CAMEL; COMPUTER MODEL; CONTROLLED STUDY; EPITOPE MAPPING; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNIZATION; NONHUMAN; PLASMODIUM VIVAX; PROTEIN ANALYSIS; PROTEIN GLYCOSYLATION; SPECIES INVASION; WESTERN BLOTTING;

ANIMALS; BLOOD GROUP ANTIGENS; CAMELS; CARRIER PROTEINS; CHEMOKINES; DUFFY BLOOD-GROUP SYSTEM; ERYTHROCYTES; HUMANS; IMMUNOGLOBULINS; INTERLEUKIN-8; PLASMODIUM VIVAX; RECEPTORS, ANTIGEN; RECEPTORS, CELL SURFACE; RECEPTORS, CHEMOKINE; RECOMBINANT PROTEINS;

CAMELIDAE; CAMELUS DROMEDARIUS; PLASMODIUM VIVAX;

EID: 77956759905     PISSN: 1420682X     EISSN: 14209071     Source Type: Journal    
DOI: 10.1007/s00018-010-0387-6     Document Type: Article

References (81)

1. AO Pogo A Chaudhuri 2000 The Duffy protein: a malarial and chemokine receptor Semin Hematol 37 122 129 10.1016/S0037-1963(00)90037-4 10791881 1:CAS:528:DC%2BD3cXjtVynurs%3D
2. A Rot 2005 Contribution of Duffy antigen to chemokine function Cytokine Growth Factor Rev 6 687 694 10.1016/j.cytogfr.2005.05.011 1:CAS:528: DC%2BD2MXhtFKmsr%2FM (Pubitemid 41505524)
3. A Rot R Horuk 2009 The duffy antigen receptor for chemokines Methods Enzymol 461 191 206 10.1016/S0076-6879(09)05409-3 19480920 1:CAS:528: DC%2BD1MXptlynsLg%3D
4. C Tournamille C Le Van Kim P Gane JP Cartron Y Colin 1995 Molecular basis and PCR-DNA typing of the Fya/fyb blood group polymorphism Hum Genet 95 407 410 10.1007/BF00208965 7705836 1:CAS:528:DyaK2MXmtVWlsrs%3D
5. Nichols ME, Rubinstein P, Barnwell J, Rodriguez de Cordoba S, Rosenfield RE (1987) A new human Duffy blood group specificity defined by a murine monoclonal antibody. Immunogenetics and association with susceptibility to Plasmodium vivax. J Exp Med 166:776-785
6. K Wasniowska Y Petit-LeRoux C Tournamille C Le van Kim JP Cartron Y Colin E Lisowska D Blanchard 2002 Structural characterization of the epitope recognized by the new anti-Fy6 monoclonal antibody NaM 185-2C3 Transfus Med 12 205 211 10.1046/j.1365-3148.2002.00373.x 12164140 1:STN:280: DC%2BD38vgvFOnsw%3D%3D (Pubitemid 34685876)
7. C Tournamille C Le van Kim P Gane PY Le Pennec F Roubinet J Babinet JP Cartron Y Colin 1998 Arg89Cys substitution results in very low membrane expression of the Duffy antigen/receptor for chemokines in Fy(x) individuals Blood 92 2147 2156 9731074 1:CAS:528:DyaK1cXmtVOgsLk%3D
8. C Tournamille Y Colin JP Cartron C Le Van Kim 1995 Disruption of a GATA motif in the Duffy gene promoter abolishes erythroid gene expression in Duffy-negative individuals Nat Genet 10 224 228 10.1038/ng0695-224 7663520 1:CAS:528:DyaK2MXmtFCqt7k%3D
9. SC Peiper ZX Wang K Neote AW Martin HJ Showell MJ Conklyn K Ogborne TJ Hadley ZH Lu J Hesselgesser R Horuk 1995 The Duffy antigen/receptor for chemokines (DARC) is expressed in endothelial cells of Duffy negative individuals who lack the erythrocyte receptor J Exp Med 181 1311 1317 10.1084/jem.181.4.1311 7699323 1:CAS:528:DyaK2MXkslWntro%3D
10. R Horuk A Martin J Hesselgesser T Hadley ZH Lu ZX Wang SC Peiper 1996 The Duffy antigen receptor for chemokines: structural analysis and expression in the brain J Leukoc Biol 59 29 38 8558064 1:CAS:528:DyaK28XnslCjtA%3D%3D
11. M Rios A Chaudhuri G Mallinson L Sausais AE Gomensoro-Garcia J Hannon S Rosenberger J Poole G Burgess O Pogo M Reid 2000 New genotypes in Fy(a-b-) individuals: nonsense mutations (Trp to stop) in the coding sequence of either FY A or FY B Br J Haematol 108 448 454 10.1046/j.1365-2141.2000.01882.x 10691880 1:CAS:528:DC%2BD3cXitFCgsb0%3D (Pubitemid 30143666)
12. LH Miller SJ Mason DF Clyde MH McGinniss 1976 The resistance factor to Plasmodium vivax in blacks The Duffy-blood-group genotype, FyFy, N Engl J Med 295 302 304 1:STN:280:DyaE283itVarsA%3D%3D
13. C Tournamille A Filipe C Badaut MM Riottot S Longacre JP Cartron C Le Van Kim Y Colin 2005 Fine mapping of the Duffy antigen binding site for the Plasmodium vivax Duffy-binding protein Mol Biochem Parasitol 144 100 103 10.1016/j.molbiopara.2005.04.016 16024106 1:CAS:528:DC%2BD2MXhtVGqu7fN (Pubitemid 41393375)
14. D Hans P Pattnaik A Bhattacharyya AR Shakri SS Yazdani M Sharma H Choe M Farzan CE Chitnis 2005 Mapping binding residues in the Plasmodium vivax domain that binds Duffy antigen during red cell invasion Mol Microbiol 55 1423 1434 10.1111/j.1365-2958.2005.04484.x 15720551 1:CAS:528:DC%2BD2MXitl2rurs%3D (Pubitemid 40342070)
15. H Choe MJ Moore CM Owens PL Wright N Vasilieva W Li AP Singh R Shakri CE Chitnis M Farzan 2005 Sulphated tyrosines mediate association of chemokines and Plasmodium vivax Duffy binding protein with the Duffy antigen/receptor for chemokines (DARC) Mol Microbiol 55 1413 1422 10.1111/j.1365-2958.2004.04478.x 15720550 1:CAS:528:DC%2BD2MXitl2ruro%3D (Pubitemid 40342069)
16. SK Singh R Hora H Belrhali CE Chitnis A Sharma 2006 Structural basis for Duffy recognition by the malaria parasite Duffy-binding-like domain Nature 439 741 744 10.1038/nature04443 16372020 1:CAS:528:DC%2BD28XhtFyktL8%3D (Pubitemid 43237622)
17. CL King P Michon AR Shakri A Marcotty D Stanisic PA Zimmerman JL Cole-Tobian I Mueller CE Chitnis 2008 Naturally acquired Duffy-binding protein-specific binding inhibitory antibodies confer protection from blood-stage Plasmodium vivax infection Proc Natl Acad Sci USA 105 8363 8836 10.1073/pnas.0800371105 18523022 (Pubitemid 351904761)
18. BT Grimberg R Udomsangpetch J Xainli A McHenry T Panichakul J Sattabongkot L Cui M Bockarie C Chitnis J Adams PA Zimmerman CL King 2007 Plasmodium vivax invasion of human erythrocytes inhibited by antibodies directed against the Duffy binding protein PLoS Med 4 e337 10.1371/journal.pmed.0040337 18092885 1:CAS:528:DC%2BD1cXmvVSlsb4%3D
19. R Rosenberg 2007 Plasmodium vivax in Africa: hidden in plain sight? Trends Parasitol 23 193 196 10.1016/j.pt.2007.02.009 17360237 (Pubitemid 46618122)
20. Cavasini CE, de Mattos LC, Couto AA, Couto VS, Gollino Y, Moretti LJ, Bonini-Domingos CR, Rossit AR, Castilho L, Machado RL (2007) Duffy blood group gene polymorphisms among malaria vivax patients in four areas of the Brazilian Amazon region. Malar J 6:167-175
21. D Menard C Barnadas C Bouchier C Henry-Halldin L Gray A Ratsimbasoa V Thonier J-F Carod O Domarle Y Colin O Bertrand J Picot C King B Grimberg O Mercereau-Puijalon P Zimmerman 2010 Plasmodium vivax clinical malaria is commonly observed in Duffy-negative Malagasy people Proc Natl Acad Sci USA 107 5967 5971 10.1073/pnas.0912496107 20231434
22. Chaudhuri A, Polyakova J, Zbrzezna V, Williams K, Gulati S, Pogo AO (1993) Cloning of glycoprotein D cDNA, which encodes the major subunit of the Duffy blood group system and the receptor for the Plasmodium vivax malaria parasite. Proc Natl Acad Sci USA 90:10793-10797
23. S Iwamoto T Omi E Kajii S Ikemoto 1995 Genomic organization of the glycoprotein D gene: Duffy blood group Fya/Fyb alloantigen system is associated with a polymorphism at the 44-amino acid residue Blood 85 622 626 7833467 1:CAS:528:DyaK2MXjtlCqt7Y%3D
24. R Horuk CE Chitnis WC Darbonne TJ Colby A Rybicki TJ Hadley LH Miller 1993 A receptor for the malarial parasite Plasmodium vivax: the erythrocyte chemokine receptor Science 261 1182 1184 10.1126/science.7689250 7689250 1:CAS:528:DyaK3sXlsFyjsLk%3D
25. MC Szabo KS Soo A Zlotnik TJ Schall 1995 Chemokine class differences in binding to the Duffy antigen-erythrocyte chemokine receptor J Biol Chem 270 25348 25351 10.1074/jbc.270.43.25348 7592697 1:CAS:528:DyaK2MXovFylt7o%3D
26. GJ Graham 2009 D6 and the atypical chemokine receptor family: novel regulators of immune and inflammatory processes Eur J Immunol 39 342 351 10.1002/eji.200838858 19130487 1:CAS:528:DC%2BD1MXitlCqu74%3D
27. AB Lentsch 2002 The Duffy antigen/receptor for chemokines (DARC) and prostate cancer. A role as clear as black and white? FASEB J 16 1093 1095 10.1096/fj.02-0066hyp 12087071 1:CAS:528:DC%2BD38XltlKhs7g%3D (Pubitemid 34753516)
28. CL Addison JA Belperio MD Burdick RM Strieter 2004 Overexpression of the duffy antigen receptor for chemokines (DARC) by NSCLC tumor cells results in increased tumor necrosis BMC Cancer 4 1 28 10.1186/1471-2407-4-28 1:CAS:528:DC%2BD2cXlvFaisb8%3D (Pubitemid 40180304)
29. J Wang ZL Ou YF Hou JM Luo ZZ Shen J Ding ZM Shao 2006 Enhanced expression of Duffy antigen receptor for chemokines by breast cancer cells attenuates growth and metastasis potential Oncogene 25 7201 7211 10.1038/sj.onc.1209703 16785997 1:CAS:528:DC%2BD28Xht1SrtbrF (Pubitemid 44764189)
30. J Vandercappellen J Van Damme S Struyf 2008 The role of CXC chemokines and their receptors in cancer Cancer Lett 267 226 244 10.1016/j.canlet.2008.04. 050 18579287 1:CAS:528:DC%2BD1cXovF2hsLc%3D
31. L Gardner C Wilson AM Patterson B Bresnihan O FitzGerald MA Stone BA Ashton J Middleton 2006 Temporal expression pattern of Duffy antigen in rheumatoid arthritis: up-regulation in early disease Arthritis Rheum 54 2022 2026 10.1002/art.21909 16732566 (Pubitemid 43877955)
32. C Murdoch A Finn 2000 Chemokine receptors and their role in inflammation and infectious diseases Blood 95 3032 3043 10807766 1:CAS:528: DC%2BD3cXjt1equrk%3D
33. S Segerer H Regele KM Mac R Kain JP Cartron Y Colin D Kerjaschk D Schlondorff 2000 The Duffy antigen receptor for chemokines is up-regulated during acute renal transplant rejection and crescentic glomerulonephritis Kidney Int 58 1546 1556 10.1046/j.1523-1755.2000.00316.x 11012889 1:CAS:528: DC%2BD3cXntlyltbs%3D
34. A Zarbock J Bishop H Müller M Schmolke K Buschmann H Van Aken K Singbartl 2010 Chemokine homeostasis vs chemokine presentation during severe acute lung injury, the other side of the Duffy antigen receptor for chemokines Am J Physiol Lung Cell Mol Physiol 298 L462 L471 10.1152/ajplung.00224.2009 20061440 1:CAS:528:DC%2BC3cXjsFGgur0%3D
35. A Chakera RM Seeber AE John KA Eidne DR Greaves 2008 The duffy antigen/receptor for chemokines exists in an oligomeric form in living cells and functionally antagonizes CCR5 signaling through hetero-oligomerization Mol Pharmacol 73 1362 1370 10.1124/mol.107.040915 18230715 1:CAS:528: DC%2BD1cXlsVWgtbc%3D (Pubitemid 351574826)
36. I Comerford RJ Nibbs 2005 Post-translational control of chemokines, a role for decoy receptors ? Immunol Lett 4 163 174 10.1016/j.imlet.2004.08.018 1:CAS:528:DC%2BD2cXhtVCltrjJ (Pubitemid 39600772)
37. A Rot 2005 Contribution of Duffy antigen to chemokine function Cytokine Growth Factor Rev 16 687 694 10.1016/j.cytogfr.2005.05.011 16054417 1:CAS:528:DC%2BD2MXhtFKmsr%2FM (Pubitemid 41505524)
38. M Pruenster A Rot 2006 Throwing light on DARC Biochem Soc Trans 34 1005 1008 10.1042/BST0341005 17073738 1:CAS:528:DC%2BD28XhtFKgtLjK (Pubitemid 46768977)
39. W He S Neil H Kulkarni E Wright BK Agan VC Marconi MJ Dolan RA Weiss SK Ahuja 2008 Duffy antigen receptor for chemokines mediates trans-infection of HIV-1 from red blood cells to target cells and affects HIV-AIDS susceptibility Cell Host Microbe 4 52 62 10.1016/j.chom.2008.06.002 18621010 1:CAS:528:DC%2BD1cXptF2mu70%3D (Pubitemid 351944053)
40. KC Horne X Li LP Jacobson F Palella BD Jamieson JB Margolick J Martinson V Turkozu K Visvanathan IJ Woolley 2009 Duffy antigen polymorphisms do not alter progression of HIV in African Americans in the MACS cohort Cell Host Microbe 5 415 417 10.1016/j.chom.2009.04.013 19454342 1:CAS:528:DC%2BD1MXosVClurc%3D
41. Julg B, Reddy S, van der Stok M, Kulkarni S, Qi Y, Bass S, Gold B, Nalls MA, Nelson GW, Walker BD, Carrington M, Ndung'u T (2009) Lack of Duffy antigen receptor for chemokines, no influence on HIV disease progression in an African treatment-naïve population. Cell Host Microbe 5:413-415
42. Winkler CA, An P, Johnson R, Nelson GW, Kirk G.(2009) Expression of Duffy antigen receptor for chemokines (DARC) has no effect on HIV-1 acquisition or progression to AIDS in African Americans. Cell Host Microbe 5:411-413
43. Walley NM, Julg B, Dickson SP, Fellay J, Ge D, Walker BD, Carrington M, Cohen MS, de Bakker PI, Goldstein DB, Shianna KV, Haynes BF, Letvin NL, McMichael AJ, Michael NL, Weintrob AC (2009) The Duffy antigen receptor for chemokines null promoter variant does not influence HIV-1 acquisition or disease progression. Cell Host Microbe, 5:408-410
44. Z Beck BK Brown L Wieczorek KK Peachman GR Matyas VR Polonis M Rao CR Alving 2009 Human erythrocytes selectively bind and enrich infectious HIV-1 virions PLoS One 4 e8297 10.1371/journal.pone.0008297 20011536 1:CAS:528:DC%2BD1MXhsFOmsr7N
45. H Kulkarni VC Marconi W He ML Landrum JF Okulicz J Delmar D Kazandjian J Castiblanco SS Ahuja EJ Wright RA Weiss RA Clark MJ Dolan SK Ahuja 2009 The Duffy-null state is associated with a survival advantage in leukopenic HIV-infected persons of African ancestry Blood 114 2783 2792 19620399 1:CAS:528:DC%2BD1MXht1eit7jF
46. C Hamers-Casterman T Atarhouch S Muyldermans G Robinson C Hamers EB Songa N Bendahman R Hamers 1993 Naturally occurring antibodies devoid of light chains Nature 363 446 448 10.1038/363446a0 8502296 1:CAS:528:DyaK3sXlslyqs7k%3D (Pubitemid 23179389)
47. S Muyldermans TN Baral VC Retamozzo P De Baetselier E De Genst J Kinne H Leonhardt S Magez VK Nguyen H Revets U Rothbauer B Stijlemans S Tillib U Wernery L Wyns G Hassanzadeh-Ghassabeh D Saerens 2009 Camelid immunoglobulins and nanobody technology Vet Immunol Immunopathol 128 178 183 10.1016/j.vetimm.2008. 10.299 19026455 1:CAS:528:DC%2BD1MXisVOgur8%3D
48. D Saerens F Frederix G Reekmans K Conrath K Jans L Brys L Huang E Bosmans G Maes G Borghs S Muyldermans 2005 Engineering camel single-domain antibodies and immobilization chemistry for human prostate-specific antigen sensing Anal Chem 77 7547 7555 10.1021/ac051092j 16316161 1:CAS:528:DC%2BD2MXhtFertLrK (Pubitemid 41746221)
49. K Conrath AS Pereira CE Martins CG Timóteo P Tavares S Spinelli J Kinne C Flaudrops C Cambillau S Muyldermans I Moura JJ Moura M Tegoni A Desmyter 2009 Camelid nanobodies raised against an integral membrane enzyme, nitric oxide reductase Protein Sci 18 619 628 19241371 1:CAS:528:DC%2BD1MXms1Wnu7w%3D
50. V Tereshko S Uysal A Koide K Margalef S Koide AA Kossiakoff 2008 Toward chaperone-assisted crystallography, protein engineering enhancement of crystal packing and X-ray phasing capabilities of a camelid single-domain antibody (VHH) scaffold Protein Sci 17 1175 1187 10.1110/ps.034892.108 18445622 1:CAS:528:DC%2BD1cXot1ehs7o%3D (Pubitemid 351930915)
51. TN Baral S Magez B Stijlemans K Conrath B Vanhollebeke E Pays S Muyldermans P De Baetselier 2006 Experimental therapy of African trypanosomiasis with a nanobody-conjugated human trypanolytic factor Nat Med 12 580 584 10.1038/nm1395 16604085 1:CAS:528:DC%2BD28Xkt1Kju74%3D
52. RB Abderrazek I Hmila C Vincke Z Benlasfar M Pellis H Dabbek D Saerens M El Ayeb S Muyldermans B Bouhaouala-Zahar 2009 Identification of potent nanobodies to neutralize the most poisonous polypeptide from scorpion venom Biochem J 424 263 272 10.1042/BJ20090697 19732033
53. FW Studier AH Rosenberg JJ Dunn JW Dubendorff 1990 Use of T7 RNA polymerase to direct expression of cloned genes Methods Enzymol 185 60 89 10.1016/0076-6879(90)85008-C 2199796 1:CAS:528:DyaK3cXlsVKltro%3D (Pubitemid 20219811)
54. FW Studier 2005 Protein production by auto-induction in high density shaking cultures Protein Expr Purif 41 207 234 10.1016/j.pep.2005.01.016 15915565 1:CAS:528:DC%2BD2MXjsFCktLw%3D
55. HM Geysen SJ Rodda TJ Mason G Tribbick PG Schoofs 1987 Strategies for epitope analysis using peptide synthesis J Immunol Methods 102 259 274 10.1016/0022-1759(87)90085-8 2443575 1:CAS:528:DyaL1cXpt1Oitg%3D%3D (Pubitemid 17139413)
56. SF Altschul TL Madden AA Schäffer J Zhang Z Zhang W Miller DJ Lipman 1997 Gapped BLAST and PSI-BLAST, a new generation of protein database search programs Nucleic Acids Res 25 3389 3402 10.1093/nar/25.17.3389 9254694 1:CAS:528:DyaK2sXlvFyhu7w%3D (Pubitemid 27359211)
57. HM Berman J Westbrook Z Feng G Gilliland TN Bhat H Weissig IN Shindyalov PE Bourne 2000 The protein data bank Nucleic Acids Res 28 235 242 10.1093/nar/28.1.235 10592235 1:CAS:528:DC%2BD3cXhvVKjt7w%3D
58. K Decanniere TR Transue A Desmyter D Maes S Muyldermans L Wyns 2001 Degenerate interfaces in antigen-antibody complexes J Mol Biol 313 473 478 10.1006/jmbi.2001.5075 11676532 1:CAS:528:DC%2BD3MXnslCrtr0%3D (Pubitemid 33052280)
59. M Dumoulin AM Last A Desmyter K Decanniere D Canet G Larsson A Spencer DB Archer J Sasse S Muyldermans L Wyns C Redfield A Matagne CV Robinson CM Dobson 2003 A camelid antibody fragment inhibits the formation of amyloid fibrils by human lysozyme Nature 424 783 788 10.1038/nature01870 12917687 1:CAS:528:DC%2BD3sXmt1antrc%3D (Pubitemid 37021708)
60. JD Thompson TJ Gibson F Plewniak F Jeanmougin DG Higgins 1997 The CLUSTAL-X windows interface, flexible strategies for multiple sequence alignment aided by quality analysis tools Nucleic Acids Res 25 4876 4882 10.1093/nar/25.24.4876 9396791 1:CAS:528:DyaK1cXntFyntQ%3D%3D (Pubitemid 28022245)
61. A Sali TL Blundell 1993 Comparative protein modelling by satisfaction of spatial restraints J Mol Biol 234 779 815 10.1006/jmbi.1993.1626 8254673 1:CAS:528:DyaK2cXnt1ylug%3D%3D (Pubitemid 24007801)
62. RA Laskowski DS Moss JM Thornton 1993 Main-chain bond lengths and bond angles in protein structures J Mol Biol 231 1049 1067 10.1006/jmbi.1993.1351 8515464 1:CAS:528:DyaK3sXltlCqur4%3D (Pubitemid 23209879)
63. N Shibuya IJ Goldstein WF Broekaert M Nsimba-Lubaki B Peeters WJ Peumans 1987 The elderberry (Sambucus nigra L.) bark lectin recognizes the Neu5Ac(alpha 2-6)Gal/GalNAc sequence J Biol Chem 262 1596 1601 3805045 1:CAS:528: DyaL2sXhslWns7s%3D
64. M Grodecka M Czerwiński M Duk E Lisowska K Waśniowska 2010 Analysis of recombinant Duffy protein-linked N-glycans using lectins and glycosidases Acta Biochim Pol 57 49 53 20234884 1:CAS:528:DC%2BC3cXktlWntbk%3D
65. M Czerwinski J Kern M Grodecka M Paprocka A Krop-Watorek K Wasniowska 2007 Mutational analysis of the N-glycosylation sites of Duffy antigen/receptor for chemokines Biochem Biophys Res Commun 356 816 821 10.1016/j.bbrc.2007.03.054 17382291 1:CAS:528:DC%2BD2sXjvFOmsL8%3D (Pubitemid 46499040)
66. C Tournamille A Filipe K Wasniowska P Gane E Lisowska JP Cartron Y Colin C Le Van Kim 2003 Structure-function analysis of the extracellular domains of the Duffy antigen/receptor for chemokines, characterization of antibody and chemokine binding sites Br J Haematol 122 1014 1023 10.1046/j.1365-2141.2003. 04533.x 12956774 1:CAS:528:DC%2BD3sXotFKns7Y%3D (Pubitemid 37174624)
67. E De Genst K Silence K Decanniere K Conrath R Loris J Kinne S Muyldermans L Wyns 2006 Molecular basis for the preferential cleft recognition by dromedary heavy-chain antibodies Proc Natl Acad Sci USA 103 4586 4591 10.1073/pnas.0505379103 16537393 1:CAS:528:DC%2BD28XjtlOjsbg%3D
68. JP Gallivan DA Dougherty 1999 Cation-pi interactions in structural biology Proc Natl Acad Sci USA 96 9459 9464 10.1073/pnas.96.17.9459 10449714 1:CAS:528:DyaK1MXlsVymsr8%3D (Pubitemid 29398752)
69. VK Nguyen R Hamers L Wyns S Muyldermans 2000 Camel heavy-chain antibodies : diverse germline V(H)H and specific mechanisms enlarge the antigen-binding repertoire EMBO J 19 921 930 10.1093/emboj/19.5.921 10698934 1:CAS:528:DC%2BD3cXitVyrsrw%3D
70. Handel TM, Horuk R (2010) Duffy antigen inhibitors, useful therapeutics for malaria? Trends Parasitol, (in press). doi: 10.1016/j.pt.2010.03.010
71. LJ Kasehagen I Mueller B Kiniboro MJ Bockarie JC Reeder JW Kazura W Kastens DT McNamara C King CC Whalen PA Zimmerman 2007 Reduced Plasmodium vivax erythrocyte infection in PNG Duffy-negative heterozygotes PLoS One 2 e336 10.1371/journal.pone.0000336 17389925 1:CAS:528:DC%2BD2sXkvVWhsrY%3D
72. SR Albuquerque F de Oliveira Cavalcante EC Sanguino L Tezza F Chacon L Castilho MC Dos Santos 2010 FY polymorphisms and vivax malaria in inhabitants of Amazonas State, Brazil Parasitol Res 106 1049 1053 10.1007/s00436-010-1745-x 20162434
73. N Mariette C Barnadas C Bouchier M Tichit D Ménard 2008 Country-wide assessment of the genetic polymorphism in Plasmodium falciparum and Plasmodium vivax antigens detected with rapid diagnostic tests for malaria Malar J 7 219 227 10.1186/1475-2875-7-219 18957099 1:CAS:528:DC%2BD1cXhsFWmsr7J
74. Z Johnson M Schwarz CA Power TN Wells AE Proudfoot 2005 Multi-faceted strategies to combat disease by interference with the chemokine system Trends Immunol 26 268 274 10.1016/j.it.2005.03.001 15866240 1:CAS:528: DC%2BD2MXjslKjs7k%3D (Pubitemid 41556850)
75. TN Wells CA Power JP Shaw AE Proudfoot 2006 Chemokine blockers-therapeutics in the making? Trends Pharmacol Sci 27 41 47 10.1016/j.tips.2005.11.001 16310864 1:CAS:528:DC%2BD28XksVSitQ%3D%3D (Pubitemid 43063123)
76. H Furthmayr VT Marchesi 1976 Subunit structure of human erythrocyte glycophorin A Biochemistry 15 1137 1144 10.1021/bi00650a028 175830 1:CAS:528:DyaE28XhtFOgsbo%3D
77. R Grisshammer 2009 Purification of recombinant G-protein-coupled receptors Methods Enzymol 463 631 645 10.1016/S0076-6879(09)63036-6 19892196 1:CAS:528:DC%2BC3cXmt12hug%3D%3D
78. PE Blackburn 2004 Purification and biochemical characterization of the D6 chemokine receptor Biochem J 379 263 272 10.1042/BJ20031266 14723600 1:CAS:528:DC%2BD2cXjtVSgsLg%3D (Pubitemid 38570098)
79. J Field J Nikawa D Broekv B MacDonaldv L Rodgers IA Wilson RA Lerner M Wigler 1988 Purification of a RAS-responsive adenylyl cyclase complex from Saccharomyces cerevisiae by use of an epitope addition method Mol Cell Biol 8 2159 2165 2455217 1:CAS:528:DyaL1cXktVart7s%3D
80. P Chelikani PJ Reeves UL Rajbhandaryv HG Khorana 2006 The synthesis and high-level expression of a beta2-adrenergic receptor gene in a tetracycline-inducible stable mammalian cell line Protein Sci 15 1433 1440 10.1110/ps.062080006 16731977 1:CAS:528:DC%2BD28XlsVKqurg%3D (Pubitemid 43800014)
81. I Mouro-Chanteloup C Cochet M Chami S Genetet N Zidi-Yahiaoui A Engel Y Colin O Bertrand P Ripoche 2010 Functional reconstitution into liposomes of purified human RhCG ammonia channel PLoS One 5 e8921 10.1371/journal.pone. 0008921 20126667 1:CAS:528:DC%2BC3cXhsV2ksrY%3D